Tech giant Samsung has teamed up with decentralized science (DeSci) and healthcare artificial intelligence protocol Galeon to offer AI training data from its ultrasound devices.
In a recent announcement shared with Cointelegraph, Samsung revealed that it will be integrating its ultrasound equipment with Galeon’s electronic health record (EHR) platform. Galeon CEO Loïc Brotons mentioned that the EHR is currently operational in 18 interconnected hospitals, including facilities in France such as Rouen University Hospital, Caen University Hospital, Toulon Hospital, and Sud Francilien Hospital.
The collaboration between Samsung and Galeon aims to enhance medical data accessibility while prioritizing privacy. Brotons emphasized that the data is not stored onchain; only the AI algorithm functions onchain with complete transparency on its operations. Additionally, all data undergoes anonymization before training to comply with privacy regulations.
This partnership enables healthcare providers to train AI models without centralizing patient information. Each hospital or institution maintains control over their data while benefiting from shared algorithm training.
The Galeon Team. Source: Galeon
Related: Blockchain and AI can enable advanced personalization in healthcare
Decentralized Science Revolutionizing Medicine
The healthcare sector is witnessing significant advancements in decentralized science. Alex Dobrin from VitaDAO, a decentralized collective focused on extending human lifespans, highlighted that the time and cost constraints of drug development are driving individuals to take control of their health.
In a recent breakthrough, DeSci decentralized autonomous organization HydraDAO reported successful experiments where rats with fully transected spines regained mobility within five days. Such developments are attracting attention from investors looking to support innovative healthcare solutions.
Related: Decentralized science meets AI — legacy institutions aren’t ready
Investor Interest in DeSci
Bio Protocol, a DeSci platform, secured funding from investors like Maelstrom Fund and Animoca Brands in a $6.9 million funding round. This followed an earlier investment from Binance Labs, the venture capital arm of the popular cryptocurrency exchange, in late 2024.
Data plays a crucial role in these projects, with DeSci platforms actively seeking to acquire genetic data from bankrupt DNA testing service 23andMe.
Magazine: Memecoin degeneracy is funding groundbreaking anti-aging research